Organon & Co.
S&P 500OGN/Healthcare · Drug Manufacturers - General/NYSE
Dividend Yield
0.60%
$0.08 · Annual Dividend
Dividend Safety Rating
OGN's dividend appears safe and well-supported. Strengths include a 8.6% earnings payout ratio & 3.8% fcf payout ratio. Areas of concern: 1.8x interest coverage & 62.7% net debt / total assets.
Based on 14 of 15 metrics
Strengths
- Earnings Payout Ratio: 8.6%Low earnings payout ratio leaves room to grow the dividend.
- FCF Payout Ratio: 3.8%Free cash flow comfortably covers the dividend.
- CFO Payout Ratio: 12.8%Operating cash flow strongly supports the payout.
Risks
- Debt-to-Equity: 948.9Debt-to-equity is elevated for the sector.
- Interest Coverage: 1.8xInterest coverage is thin relative to debt servicing.
- Net Debt / Total Assets: 62.7%Net debt is high relative to total assets.
Payout & Coverage
SafeBalance Sheet
WarningProfitability
SafeDividend Track Record
SafeAbout Organon & Co.
Organon & Co. is a science-based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies. Its primary focus areas include women’s health, biosimilars, and established brands, addressing key therapeutic needs in reproductive health, dermatology, and chronic disease management. The company offers products such as contraceptives, menopause treatments, fertility solutions, and oncology biosimilars, alongside a range of mature branded medicines for pain, respiratory conditions, and cardiovascular disorders. Organon & Co. operates across major geographies, with significant presence in Europe, Canada, the United States, Asia Pacific, and Japan. It emphasizes research and development to advance therapies in women’s health and biosimilars, while maintaining a strong lineup of established products that provide reliable treatment options worldwide. Founded in 2020 and headquartered in Jersey City, New Jersey, Organon & Co. plays a vital role in the pharmaceutical sector by bridging innovation with accessible healthcare solutions for diverse patient populations.
Dividend Overview
Dividend Yield
0.60%
Annual Dividend
$0.08
Frequency
Quarterly
Payout Ratio
8.60%
FCF Payout Ratio
3.77%
52-Week Range
$5.69 - $13.49
Dividend History (2016–2025)
OGN annual dividend per share and yield history
Earnings & Profitability
OGN earnings per share and net profit margin
Key Dates
Last Ex-Dividend Date
May 11, 2026
Last Payment Date
June 11, 2026
Dividend Growth
3-Year Dividend CAGR
-32.79%
5-Year Dividend CAGR
N/A
10-Year Dividend CAGR
N/A
3-Year Total Growth
-69.64%
5-Year Total Growth
N/A
10-Year Total Growth
N/A
Income Calculator
Frequently Asked Questions
What is OGN's current dividend yield?
When is OGN's next dividend payment date?
How much does OGN pay in dividends per year?
Has OGN been increasing its dividend?
Is OGN's dividend safe?
How is OGN's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track OGN Dividends with OnlyDividends
What will OGN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.